Literature DB >> 1117977

Circadian variation of integrated concentration of growth hormone in children and adults.

L P Plotnick, R G Thompson, A Kowarski, L de Lacerda, C J Migeon, R M Blizzard.   

Abstract

A portable constant withdrawal pump was used to determine consecutive 30-min integrated concentrations of growth hormone (ICGH) for a 24-h period in 18 normal subjects, ages 5 to 28 yr. Seven prepubertal, 5 pubertal and 6 young adult subjects were studied under conditions of normal activity. Pubertal, prepubertal, and adult subjects had peaks during waking hours as well as during sleep, but peaks in the adults were usually lower than in the children. Using an analysis of variance, a significant (P smaller than 0.01) downward trend of ICGH was observed to occur during sleep. During waking hours a significant variation (P smaller than 0.01 by analysis of variance) was found with low levels in the first few hours after awakening and an upward trend as the evening approached. Food intake had no significant effect on ICGH nor did the introduction of the indwelling catheter. The mean apparent half-life values of growth hormone calculated on the basis of 87 episodes with 3 or more points on the downslope was 40.1 min. This is significantly higher than the known true half-life of the hormone, suggesting that complete secretory inactivity after a secretory episode is an infrequent event.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1117977     DOI: 10.1210/jcem-40-2-240

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Does growth hormone influence the severity of phosphopenic rickets?

Authors:  T Bistritzer; S A Chalew; A Hanukoglu; K M Armour; P J Haney; A A Kowarski
Journal:  Eur J Pediatr       Date:  1990-11       Impact factor: 3.183

2.  Long-term GH treatment of GH-deficient adults: comparison between one and two daily injections.

Authors:  C Höybye; M Rudling
Journal:  J Endocrinol Invest       Date:  2006-12       Impact factor: 4.256

3.  A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.

Authors:  E Ghigo; E Imperiale; G M Boffano; E Mazza; J Bellone; E Arvat; M Procopio; S Goffi; A Barreca; P Chiabotto
Journal:  J Endocrinol Invest       Date:  1990-04       Impact factor: 4.256

Review 4.  Regulation of growth hormone secretion in man: a review.

Authors:  D G Johnston; R R Davies; R W Prescott
Journal:  J R Soc Med       Date:  1985-04       Impact factor: 5.344

5.  Growth and endocrine function after renal transplantation.

Authors:  L Rees; S A Greene; P Adlard; J Jones; G B Haycock; S P Rigden; M Preece; C Chantler
Journal:  Arch Dis Child       Date:  1988-11       Impact factor: 3.791

6.  Dopamine receptor alteration in schizophrenia: neuroendocrine evidence.

Authors:  J Rotrosen; B M Angrist; S Gershon; E J Sachar; F S Halpern
Journal:  Psychopharmacology (Berl)       Date:  1976-12-21       Impact factor: 4.530

Review 7.  Measuring growth hormone and insulin-like growth factor-I in infants: what is normal?

Authors:  Colin Patrick Hawkes; Adda Grimberg
Journal:  Pediatr Endocrinol Rev       Date:  2013-12

8.  Demonstration that circulating 1 alpha, 25-dihydroxyvitamin D is loosely regulated in normal children.

Authors:  P H Stern; A B Taylor; N H Bell; S Epstein
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

9.  Evaluation of growth hormone in thalassaemic boys with failed puberty: spontaneous versus provocative test.

Authors:  R Chatterjee; M Katz; T Cox; H Bantock
Journal:  Eur J Pediatr       Date:  1993-09       Impact factor: 3.183

10.  Growth and endocrine function in steroid sensitive nephrotic syndrome.

Authors:  L Rees; S A Greene; P Adlard; J Jones; G B Haycock; S P Rigden; M Preece; C Chantler
Journal:  Arch Dis Child       Date:  1988-05       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.